Valuation: COMPASS Pathways plc

Market Cap 156.06Cr 139.3Cr 129.47Cr 117.77Cr 221.56Cr 15TCr 225.56Cr 1.56TCr 608.49Cr 7.71TCr 585.66Cr 573.25Cr 25TCr P/E 2026 *
-5.24x
P/E 2027 * -6.73x
Enterprise Value 120.16Cr 107.26Cr 100Cr 91Cr 170.6Cr 11TCr 173.67Cr 1.2TCr 468.52Cr 5.94TCr 450.94Cr 441.38Cr 19TCr EV / Sales 2026 *
-
EV / Sales 2027 * 28.4x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day+3.15%
1 week+0.92%
Current month-6.95%
1 month-16.18%
3 months-13.04%
6 months+94.21%
Current year+67.75%
1 week 10.97
Extreme 10.97
12.08
1 month 10.97
Extreme 10.97
15.55
Current year 4.88
Extreme 4.88
15.87
1 year 4.88
Extreme 4.88
15.87
3 years 2.25
Extreme 2.25
15.87
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 01/08/2022
Director of Finance/CFO 54 01/03/2024
Chief Tech/Sci/R&D Officer 66 01/05/2024
Director TitleAgeSince
Chairman 74 29/03/2024
Director/Board Member 69 01/04/2020
Director/Board Member 67 01/03/2021
Date Insider Type Main position Quantity % Market Cap. Importance
03/08/26 Tax

Chief Executive Officer

-5,962 0.0062%
27/05/26 Free

Director

21,110 0.0220%
27/05/26 Free

Director

21,110 0.0220%
Change 5-day change 1-year change 3-year change Capi.($)
+3.02%+0.92%+69.47%+85.20% 156.06Cr
+0.21%-7.67%+61.07%+71.32% 6.89TCr
+1.66%+7.51%+8.12%+61.40% 5.19TCr
+3.14%+7.17%+12.48%+41.70% 4.87TCr
+3.19%+4.85%+33.63%+36.41% 4.31TCr
-1.56%+1.84%+286.58%+461.52% 4.15TCr
+6.67%+6.71%+18.17%+114.79% 4TCr
+1.28%-0.76%+12.67%+45.10% 3.06TCr
-2.21%-14.22%+40.33%-0.94% 2.6TCr
+1.52%-1.85%-13.40%-6.82% 2.23TCr
Average +1.71%-3.87%+52.91%+90.97% 3.75TCr
Weighted average by Cap. +1.63%-3.49%+54.86%+98.17%

Financials

2026 *2027 *
Net sales - 3.97Cr 3.54Cr 3.29Cr 3Cr 5.64Cr 376Cr 5.74Cr 40Cr 15Cr 196.18Cr 15Cr 15Cr 627.75Cr
Net income -30Cr -27Cr -25Cr -23Cr -42Cr -2.83TCr -43Cr -297.54Cr -116.42Cr -1.48TCr -112.05Cr -109.67Cr -4.72TCr -25Cr -22Cr -21Cr -19Cr -36Cr -2.39TCr -36Cr -251.01Cr -98Cr -1.24TCr -95Cr -93Cr -3.98TCr
Net Debt -36Cr -32Cr -30Cr -27Cr -51Cr -3.4TCr -52Cr -357.75Cr -139.97Cr -1.77TCr -134.72Cr -131.87Cr -5.68TCr -43Cr -39Cr -36Cr -33Cr -61Cr -4.09TCr -62Cr -430.65Cr -168.5Cr -2.14TCr -162.18Cr -158.74Cr -6.83TCr
Projected Income Statement - Annual - COMPASS Pathways plc
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
16/26/16 $11.60 +2.88% 15,36,069
14/26/14 $11.27 +1.17% 25,36,082
13/26/13 $11.14 -3.38% 18,75,023
12/26/12 $11.53 -3.92% 19,60,410
09/26/09 $12.00 +4.62% 22,84,844
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - COMPASS Pathways plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
11.27USD
Average target price
23.75USD
Spread / Average Target
+110.74%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - COMPASS Pathways plc
  1. Stock Market
  2. Stocks
  3. CMPS Stock